Investigation of Ultrasonographic Measurements of Lower Extremity Nerves in Type 2 Diabetes Patients With Peripheral Polyneuropathy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

About this trial

The aim of this study is to quantitatively evaluate ultrasonographic measurements of the lower extremity nerves in patients diagnosed with diabetic polyneuropathy and to investigate the relationship with gait, static and dynamic balance performance.

In this study, we aimed to investigate the effect of ultrasonographic findings of lower extremity nerves on quality of daily life, physical activity, gait and balance in patients with diabetic peripheral polyneuropathy.

Eligibility criteria

Qualifiers

Being between the ages of 18-65

Being literate

Signed a voluntary consent form agreeing to participate in the study

Diagnosed with Type 2 Diabetes based on at least one of the following diagnostic criteria: fasting plasma glucose ≥ 126 mg/dl, 2-hour plasma glucose ≥ 200 mg/dl in an oral glucose tolerance test, HbA1c ≥ 6.5%, or diabetes symptoms (excessive thirst, eating, urination, and weight loss) + random plasma glucose ≥ 200 mg/dl. (14)

Disqualifiers

Individuals under 18 years old and over 65 years old

Diagnosed with Type 1 diabetes

Use of medications that can cause polyneuropathy

Other causes of neuropathic pain (lumbar radiculopathy, spinal stenosis, -hereditary, inflammatory, entrapment neuropathies)

Trial design

Treatments tested in this trial

  • Ultrasonography
  • Biodex Balance System
  • Douleur Neuropathique 4 (DN4) Pain Scale
  • Numeric Rating Scale
  • Toronto Clinical Neuropathy Score
  • Six-Minute Walk Test
  • SF-12 Quality of Life Scale
  • International Physical Activity Questionnaire-Short Form (IPAQ)
  • Tuning Fork Vibration Sense
  • Timed Up and Go Test
  • Physical Examination

Treatment groups

86 Participants
are divided into 2 treatment groups